Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration | Scientific Reports
Diagnostics | Free Full-Text | Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer's Disease
Novel form of Alzheimer's protein found in spinal fluid indicates stage of the disease – Washington University School of Medicine in St. Louis
Halberd Eliminates 100% of Tau Protein From CSF - The 9th of 10 Target Neurodegenerative Disease Antigens | BioSpace
Alzheimer disease pathology and the cerebrospinal fluid proteome | Alzheimer's Research & Therapy | Full Text
Cureus | Mechanical Dilution of Beta-amyloid Peptide and Phosphorylated Tau Protein in Alzheimer's Disease: Too Simple to be True?
Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery - The Annals of Thoracic Surgery
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease | Nature Communications
![Frontiers | Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result](https://www.frontiersin.org/files/Articles/413269/fnagi-10-00409-HTML/image_m/fnagi-10-00409-g001.jpg "Frontiers | Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result")
Frontiers | Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study | Journal of Neurology, Neurosurgery & Psychiatry
Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease - ScienceDirect
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
CSF markers for incipient Alzheimer's disease - The Lancet Neurology
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity | Journal of Proteome Research
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia - ScienceDirect
Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid - ScienceDirect
BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease | Barcelona Beta
SciELO - Brasil - Biomarkers in Alzheimer disease: are we there yet? Biomarkers in Alzheimer disease: are we there yet?
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease | SpringerLink
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study | Journal of Neurology, Neurosurgery & Psychiatry
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity | Journal of Proteome Research
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study | Journal of Neurology, Neurosurgery & Psychiatry
Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans | Science Translational Medicine
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease | Molecular Systems Biology
